Credit Suisse’s Lyell Immunopharma LYEL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $275K | Buy |
6,163
+352
| +6% | +$15.7K | ﹤0.01% | 2842 |
|
|
2023
Q4 | $225K | Sell |
5,811
-741
| -11% | -$28.8K | ﹤0.01% | 2951 |
|
|
2023
Q3 | $193K | Sell |
6,552
-912
| -12% | -$26.8K | ﹤0.01% | 3025 |
|
|
2023
Q2 | $475K | Buy |
+7,464
| New | +$475K | ﹤0.01% | 2790 |
|
|
2023
Q1 | – | Hold |
0
| – | -$24 | – | 3520 |
|
|
2022
Q4 | – | Sell |
-50
| Closed | -$7K | – | 3637 |
|
|
2022
Q3 | $7K | Buy |
50
+47
| +1,567% | +$6.58K | ﹤0.01% | 3612 |
|
|
2022
Q2 | $0 | Buy |
+3
| New | – | ﹤0.01% | 4132 |
|